Company Overview
OneMedNet Corporation operates as a healthcare software entity dedicated to providing digital medical image management, exchange, and sharing solutions across the Americas, Europe, and the Middle East. The company specializes in delivering iRWD, a platform that offers regulatory-grade imaging and clinical data specifically tailored for the pharmaceutical and device manufacturing sectors. It functions within the Healthcare sector under the Health Information Services industry, a classification that reflects its role in managing critical data infrastructure for medical professionals and organizations. The company's current scale is defined by a market capitalization of $45.40 million, annual revenue of $494,000, and an employee count of 22. These figures indicate that OneMedNet is a micro-cap enterprise with a very small workforce, suggesting a niche operational footprint where revenue generation is derived from specialized software licensing or service agreements rather than broad-scale volume sales.
Financial Health
OneMedNet Corporation reported total revenue of $494,000 over the trailing twelve months, while simultaneously reporting a net income loss of $2,034,000 and an EBITDA of $-9,219,000. The substantial disparity between the modest revenue figure and the significant net loss reveals a cost structure where operating expenses and losses heavily outweigh gross receipts, resulting in a negative profit environment. Despite the accounting losses, the company reports positive free cash flow of $4.86 million, which indicates a degree of financial flexibility where cash generation from operations exceeds capital expenditures, allowing the firm to maintain liquidity without immediate external financing. However, the balance sheet presents a complex picture with cash assets totaling $149,000 against total debt obligations of $388,000, meaning the company holds less liquid cash than its recorded debt load. The debt-to-equity ratio is listed as N/A, likely due to the negative equity position implied by the losses, which complicates traditional leverage analysis. The current ratio stands at 0.29, a figure that indicates the company possesses only 29 cents of current assets for every dollar of current liabilities, signaling potential short-term liquidity constraints. Furthermore, the Return on Equity is N/A, and the Return on Assets is -197.3%, metrics that collectively reveal that management has not yet generated positive returns on the capital employed or the asset base.
Valuation Assessment
The trailing P/E ratio and forward P/E ratio are both listed as N/A, reflecting the company's status as a non-profitable entity where traditional earnings-based valuation multiples cannot be calculated. The price-to-book ratio is reported at -11.23, a negative figure that indicates the market capitalization is less than the book value of equity, often seen in distressed or loss-making companies where the market price does not reflect a premium over net assets. Alternatively, the price-to-sales ratio of 91.90 suggests the market is valuing the company primarily on its revenue potential rather than current earnings, while the EV/EBITDA of -4.94 further underscores the negative earnings profile inherent in the business. The stock has historically traded within a range defined by a 52-week high of $4.22 and a 52-week low of $0.30. Without a specific current price provided in the available facts to calculate a precise percentage deviation, the valuation metrics suggest the stock is priced based on speculative future growth expectations rather than current profitability. The beta of 1.09 indicates that the stock's price volatility is slightly higher than the broader market, moving 9% more than the benchmark index during periods of market fluctuation.
Growth & Income
OneMedNet Corporation demonstrated a revenue growth rate of 24.6% year-over-year, whereas the earnings growth rate is N/A due to the company's consistent losses. Because earnings are not growing positively, the revenue expansion implies that the company is scaling its top line while still grappling with high operating costs that suppress net income. The dividend yield is N/A, and the payout ratio is 0.0%, confirming that the company does not distribute dividends to shareholders. Consequently, the firm retains all of its earnings, albeit negative ones, and reinvests resources into operations rather than paying out cash to investors. This non-dividend profile is typical for early-stage or turnaround healthcare technology firms that prioritize operational scaling over shareholder returns. The overall growth and income profile for OneMedNet is characterized by strong top-line revenue expansion offset by significant operating losses and a complete absence of dividend income, presenting a high-risk, high-revenue-growth dynamic for investors analyzing the asset.